Falsely Elevated Tacrolimus Levels Caused by Immunoassay Interference Secondary to β‐Galactosidase Antibodies in an Infected Liver Transplant Recipient

Careful interpretation of tacrolimus levels is essential to ensure optimal immunosuppressive therapy while avoiding toxicity. Interference with tacrolimus assays may be an underreported event that has the potential to result in negative patient outcomes through unnecessary modifications of therapy....

Ausführliche Beschreibung